Michelle Renee Griffin Chinook Therapeutics, Inc. (KDNY) insider trading activity

KDNY Quotes by TradingView

Michelle Renee Griffin is Director of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 3,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

MICHELLE RENEE GRIFFIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
SELL
Sale (or disposition) back to the issuer
-
3,300 Reduced 100.0%
0 Common Stock
May 26 2023
BUY
Exercise of conversion of derivative security
-
3,300 Added 50.0%
3,300 Common Stock

Also insider at

ADPT
Adaptive Biotechnologies Corp Healthcare
Director
ACER
Acer Therapeutics Inc. Healthcare
Director
HTGM
HTG MOLECULAR DIAGNOSTICS, INC Healthcare
Director
MRG

Michelle Renee Griffin

Director
Tucson, AZ

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KDNY